International Clinical Trial: Randomized Trial of the RIGHTEST iFree 2 CGM System for Glycemic Control in Adults With Diabetes Mellitus

Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (NCT07889375) titled 'Randomized Trial of the RIGHTEST iFree 2 CGM System for Glycemic Control in Adults With Diabetes Mellitus' on Oct. 16.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Bionime Corporation

Condition: Diabetes (DM)

Intervention: Device: Continuous Glucose Monitoring (CGM)

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: May 15, 2026

Target Sample Size: 324

Countries of Recruitment: Taiwan

To know more, visit https://clinicaltrials.gov/study/NCT07889375

Disc...